GNSO Announcements

Date Title
01 August 2017 James Bladel Confirmed as the GNSO Representative to the Empowered Community Administration
19 July 2017 Post ICANN59 Meeting Report – GNSO
12 June 2017 Pre-ICANN59 Policy Report – GNSO
24 May 2017 Matthew Shears Selected for ICANN Board Director Seat 14 Position
24 May 2017 GNSO Council Supports the Cross Community Working Group on Enhancing ICANN Accountability Work Stream 2 Request for Extension of Mandate and Funding for Fiscal Year 2018
24 May 2017 GNSO Council Does Not Support Reopening Decision on Two-Character Country/Territory Codes at the Second Level
24 May 2017 GNSO Initiates the Policy Amendment Process on Specific Red Cross and Red Crescent Names
26 April 2017 GNSO Council Confirmed Liaison Appointments
26 April 2017 GNSO New gTLD Subsequent Procedures Policy Development Process Working Group Engaging with the ICANN Community
26 April 2017 GNSO Council Endorses GNSO Candidates for the Registration Directory Service Review Team (RDS-RT)
26 April 2017 GNSO Council Commented on the ICANN FY2018 Budget and Operating Plan
29 March 2017 Post ICANN58 Meeting Report of the GNSO
27 March 2017 Mark Your Calendar: Geographic Names Webinar 25 April 2017
27 February 2017 Pre-ICANN58 Policy Report – GNSO
24 February 2017 GNSO Council confirmed that the modification to procedure that implements the WHOIS conflicts with privacy law policy recommendation is consistent with the intent of the policy recommendation
24 February 2017 ICANN Board Accepts the GNSO Review Implementation Plan
24 February 2017 GNSO Policy Briefing ICANN58 Edition Published
27 January 2017 Webinar On the GNSO’s Policy Development Process On Curative Rights Protection Mechanisms for International Governmental and Non-Governmental Organizations
26 January 2017 Initial Report on the IGO-INGO Access to Curative Rights Protection Mechanisms Policy Development Process (PDP) Published for Public Comment
26 January 2017 GNSO Nominates Candidates for the Second Security, Stability & Resiliency Review Team (SSR2-RT)